Essential details regarding the new omission of breast cancer surgery paradigm and the analysis of the JCOG 1806 trial
International Journal of Clinical Oncology · 2026-08 · 31 (8) · 1732-1733
DOI: 10.1007/s10147-026-03060-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 19.05.2026. Verfasst von Henry M Kuerer. Beteiligte Einrichtung: MD Anderson Cancer Network, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. hkuerer@mdanderson.org. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- MD Anderson Cancer Network, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. hkuerer@mdanderson.org.
Zitieren
APA
Kuerer, H. M. (2026). Essential details regarding the new omission of breast cancer surgery paradigm and the analysis of the JCOG 1806 trial. International Journal of Clinical Oncology, 31(8), 1732-1733. https://doi.org/10.1007/s10147-026-03060-9
Vancouver
Kuerer HM. Essential details regarding the new omission of breast cancer surgery paradigm and the analysis of the JCOG 1806 trial. International Journal of Clinical Oncology. 2026;31(8):1732-1733. doi:10.1007/s10147-026-03060-9
BibTeX
@article{Kuerer2026,
author = {Kuerer, Henry M},
title = {Essential details regarding the new omission of breast cancer surgery paradigm and the analysis of the JCOG 1806 trial},
journal = {International Journal of Clinical Oncology},
year = {2026},
volume = {31},
number = {8},
pages = {1732--1733},
doi = {10.1007/s10147-026-03060-9}
}
EUVIMED